Edenred S.A.
EDNMY | OTC
$13.55
+$0.20 (+1.50%)
At close: Oct 30, 2026, 3:45 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.73B | 2.86B | 2.31B | 1.94B | 1.58B | 1.42B |
Cost of Revenue | 1.3B | 1.14B | 1.36B | 891M | 760M | 713M |
Gross Profit | 1.43B | 1.71B | 952M | 1.05B | 823M | 710M |
Operating Income | 864M | 1.04B | 706M | 602M | 496M | 417M |
Interest Income | 36M | 37M | 24M | 114M | 68M | 62M |
Pretax Income | 838M | 799M | 534M | 603M | 486M | 377M |
Net Income | 521M | 507M | 267M | 386M | 313M | 238M |
Selling & General & Admin | n/a | n/a | 447M | 396M | 288M | 261M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 568M | 672M | 246M | 55M | 39M | 32M |
Operating Expenses | 568M | 672M | 693M | 451M | 327M | 293M |
Interest Expense | 218M | 69M | 148M | 95M | 79M | 81M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.87B | 1.82B | 1.61B | 1.34B | 1.09B | 1.01B |
Income Tax Expense | 274M | 254M | 226M | 188M | 151M | 124M |
Shares Outstanding (Basic) | 238.49M | 245.29M | 249.03M | 248.99M | 247.73M | 244.34M |
Shares Outstanding (Diluted) | 238.49M | 252.65M | 264.47M | 264.35M | 263.03M | 245.41M |
EPS (Basic) | 2.18 | 2.07 | 1.07 | 1.55 | 1.26 | 0.97 |
EPS (Diluted) | 2.18 | 2.01 | 1.01 | 1.46 | 1.19 | 0.97 |
EBITDA | 1.13B | 1.17B | 875M | 751M | 628M | 583M |
EBIT | 864M | 929M | 670M | 602M | 496M | 458M |
Depreciation & Amortization | 266M | 245M | 346M | 149M | 132M | 125M |
Add to Watchlist
Select watchlists to add or remove EDNMY